GTEx Heart 20-29 vs 30-39 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Heart 20-29 vs 30-39 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Heart 20-29 vs 30-39 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Heart 20-29 vs 30-39 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Heart 20-29 vs 30-39 Down.

Results found

Linked to

 

Label

Description

 

Gene

nicotinamide phosphoribosyltransferase pseudogene 1

Gene

ubiquitin specific peptidase 32 pseudogene 1

Gene

MIR924 host gene

Gene

KRT7 antisense RNA 1

Gene

lncRNA osteogenesis associated

Gene

long intergenic non-protein coding RNA 2864

Gene

long intergenic non-protein coding RNA 1411

Gene

metallothionein 1J, pseudogene

Gene

long intergenic non-protein coding RNA 1235

Gene

long intergenic non-protein coding RNA 2015

  • Gene

    nicotinamide phosphoribosyltransferase pseudogene 1


  • Gene

    ubiquitin specific peptidase 32 pseudogene 1



  • Gene

    KRT7 antisense RNA 1


  • Gene

    lncRNA osteogenesis associated


  • Gene

    long intergenic non-protein coding RNA 2864


  • Gene

    long intergenic non-protein coding RNA 1411


  • Gene

    metallothionein 1J, pseudogene


  • Gene

    long intergenic non-protein coding RNA 1235


  • Gene

    long intergenic non-protein coding RNA 2015

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.